top of page
Cannformatics-HeroBanner-01 (16).png

Personalizing Medical Cannabis Treatment 

A NEW APPROACH

WATCH HOW WE ARE PERSONALIZING MEDICAL CANNABIS TREATMENT
shutterstock_1221615613 [Converted]-01 (
shutterstock_429937732 [Converted]-04.pn
SCIENCE-BASED EVALUATION

Our proprietary technology measures metabolic biomarkers to quantify how each person responds to cannabis, accounting for the genetic makeup, environmental and lifestyle factors of each individual.

PERSONALIZED TREATMENT

Our bioinformatics platform guides you to the best-fit available medical cannabis treatment, optimizing products, dosage and consumption methods to meet your wellness needs and improve quality of life.

shutterstock_429937732 [Converted]-03.pn
shutterstock_429937732 [Converted]-02.pn
AREA OF FOCUS

Initially we are focusing on Autism, with plans to expand to anxiety, pain, neurodegenerative diseases and nausea. Our platform is designed to work for virtually any medical condition treatable by cannabis.

shutterstock_1221615613 [Converted]-01 (
Scientific-Paper-Icon-Cannformatics-04.png

ASD PILOT STUDY ANNOUNCEMENT

Cannformatics Publishes Third Paper Revealing  Progress Towards Personalizing Medical Cannabis Treatment for ASD and other Neurological and Neuropyschiatric Disorders in Nature's Scientific Reports.

Untitled-1-01_edited_edited.jpg
Cannformatics_Paper-Icon-White.png

NATURE'S SCIENTIFIC REPORTS PAPER

A Machine Learning Approach for Understanding the Metabolomics Response of Children with Autism Spectrum Disorder to Medical Cannabis Treatment

shutterstock_602534855 1 (1)_edited_edit
Cannformatics_Press-Release-Icon-White.png

MACHINE LEARNING
PRESS RELEASE

Cannformatics Announces Scientific Reports Publication Revealing Groundbreaking Progress in Personalizing Medical Cannabis Treatment for ASD

shutterstock_262378664 1 (1)_edited_edit
Cannformatics_Paper-Icon-White.png

ASD STUDY
WHITE PAPER

A scientific summary of our three published papers and their potential applications.

FB Profile.png

OUR MISSION

To deliver predictable and repeatable science-based medical cannabis outcomes to improve health and quality of life.

_MG_0122-Edit%20(1)_edited.jpg
2020-06-11_outsidejacket_edited_edited.jpg
Mike%2520Siani-Rose%2520photo%2520(1)_edited_edited.jpg
Robert-McKee.jpg

OUR TEAM

We have decades of experience, with over 120 published scientific papers and patent applications an extensive background in founding, R&D, protecting IP & Data Privacy in biotech and  Pharma and marketing & branding in the cannabis industry. 

 NEW STANDARDS FOR MEDICAL CANNABIS TREATMENT

Our Commitment

We are committed to being an unbiased partner to the medical cannabis community, providing medical and scientific data to improve wellness outcomes, reduce stigma and inspire innovation across the industry.

Health Care Providers (HCP)

We partner with HCPs who recommend cannabis to their patients. Our bioinformatics platform will help HCPs understand the impact of medical cannabis treatment on each individual. If you would like to know more, please contact us.

Confidential

The privacy  and  confidentiality of your personal and medical information is important to us. Cannformatics is HIPAA-compliant. We comply with all Federal, State and local privacy and security regulations.

Cannformatics does not diagnose medical conditions, prescribe medical cannabis or recommend cannabis as a replacement for medical treatment.

bottom of page